CBIO vs AVBP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

CBIO

31.4
AI Score
VS
AVBP Wins

AVBP

42.1
AI Score

Investment Advisor Scores

CBIO

31score
Recommendation
SELL

AVBP

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO AVBP Winner
Net Income 153,942 -93.21M CBIO
Operating Income -152.63M -98.80M AVBP
ROE 0.1% -25.4% CBIO
ROA 0.1% -23.6% CBIO
Total Assets 240.29M 394.72M AVBP
Cash 213.19M 154.68M CBIO
Current Ratio 6.56 14.16 AVBP

Relative Price Performance (Last 90 Days)

CBIO 1M: +18.1% · 3M: +5.8% AVBP 1M: -7.8% · 3M: -4.0%

Current Technical Phase

CBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 58

RSI (14): 58.0 · Price: $19.41

AVBP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 42

RSI (14): 41.7 · Price: $29.00

Fundamentals Snapshot

Metric CBIO AVBP
Market Cap
Forward P/E -7.4 -7.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0%
Operating Margin -14.3% 0.0%
EPS -0.14 -3.55
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AVBP is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.